La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Antiparkinson Agents »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antioxidants (therapeutic use) < Antiparkinson Agents < Antiparkinson Agents (administration & dosage)  Facettes :

List of bibliographic references indexed by Antiparkinson Agents

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000375 (2016) Leslie Wayne Ferguson [Canada] ; Ali H. Rajput [Canada] ; Alexander Rajput [Canada]Early-onset vs. Late-onset Parkinson's disease: A Clinical-pathological Study.
001B78 (2010) R. Nandhagopal ; Andre R. Troiano ; Edwin Mak ; Michael Schulzer ; Mary Catherine Bushnell [Canada] ; Alexander Jon Stoessl [Canada]Response to Heat Pain Stimulation in Idiopathic Parkinson's Disease
001D95 (2009) Alain Dagher [Canada] ; Trevor W. RobbinsPersonality, addiction, dopamine: insights from Parkinson's disease.
003507 (2000) Chong S. Lee [Canada] ; M. Angela Cenci [Suède] ; Michael Schulzer [Canada] ; Anders Bjo Rklund [Suède]Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease
003C40 (1997) R. Grondin [Canada] ; P. J. Bedard [Canada] ; D. R. Britton [États-Unis] ; K. Shiosaki [États-Unis]Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929 : An acute study in parkinsonian levodopa-primed monkeys
004832 (1991) F. B. Jolicoeur ; R. Rivest ; S. St.-Pierre ; A. DrumhellerAntiparkinson-like effects of neurotensin in 6-hydroxydopamine lesioned rats
004897 (1990) C. Rouillard [Canada] ; P. J. Bédard [Canada] ; T. Di Paolo [Canada]Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393
005630 (????) Alfonso Fasano [Italie] ; Francesco Bove ; Maurizio Gabrielli ; Enzo Ragazzoni ; Serena Fortuna ; Annalisa Tortora ; Maria Assunta Zocco ; Stefano Marconi ; Antonio Gasbarrini ; Anna Rita BentivoglioLiquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Antiparkinson Agents" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Antiparkinson Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022